ACRV · Acrivon Therapeutics, Inc.
Market Cap
$88.28M
Shares
42.85M
Registered funds — mutual funds, ETFs and closed-end funds — whose latest Form N-PORT portfolio report holds this stock, matched by the stock's CUSIP. Each row is one fund position with its size, value and weight in that fund.
Funds holding ACRV
15 fund positions| Fund | Ticker | Balance | Value | % of Fund | Side | Reported | Open |
|---|---|---|---|---|---|---|---|
| VANGUARD TOTAL STOCK MARKET INDEX FUND | — | 545,541 | $971,063 | 0.00% | Long | 2026-06-30 | |
| VANGUARD EXTENDED MARKET INDEX FUND | — | 389,575 | $693,444 | 0.00% | Long | 2026-06-30 | |
| Ultra-Small Company Fund | BRUSX | 316,000 | $562,480 | 0.57% | Long | 2026-06-30 | |
| Fidelity Extended Market Index Fund | FSMAX | 111,335 | $178,136 | 0.00% | Long | 2026-05-31 | |
| iShares Micro-Cap ETF | IWC | 73,869 | $131,487 | 0.01% | Long | 2026-06-30 | |
| Ultra-Small Company Market Fund | BRSIX | 58,000 | $103,240 | 0.07% | Long | 2026-06-30 | |
| Range Cancer Therapeutics ETF | CNCR | 19,124 | $101,548 | 1.14% | Long | 2025-02-28 | |
| Fidelity Series Total Market Index Fund | FCFMX | 27,696 | $44,314 | 0.00% | Long | 2026-05-31 | |
| Fidelity Total Market Index Fund | FSKAX | 24,809 | $39,694 | 0.00% | Long | 2026-05-31 | |
| VANGUARD BALANCED INDEX FUND | — | 16,892 | $30,068 | 0.00% | Long | 2026-06-30 | |
| Fidelity Nasdaq Composite Index Fund | FNCMX | 18,053 | $28,885 | 0.00% | Long | 2026-05-31 | |
| 1290 VT Micro Cap Portfolio | — | 4,941 | $8,795 | 0.00% | Long | 2026-06-30 | |
| Blackstone Alternative Multi-Strategy Fund | — | 2,500 | $4,450 | 0.00% | Long | 2026-06-30 | |
| Small-Mid Cap Equity Fund | TSGUX | 468 | $3,547 | 0.00% | Long | 2024-11-30 | |
| Total Stock Market Index Trust | — | 937 | $1,668 | 0.00% | Long | 2026-06-30 |
Showing 1–15 of 15 positions
Key facts
CIK
1781174
CUSIP
004890109
13F (30d)
44 filings
44 filers
Visit website
Investor relations